Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 06, 2023

SELL
$21.94 - $26.24 $7,459 - $8,921
-340 Reduced 88.08%
46 $1,000
Q3 2022

Nov 02, 2022

BUY
$22.0 - $31.87 $726 - $1,051
33 Added 9.35%
386 $8,000
Q2 2022

Aug 12, 2022

SELL
$26.4 - $30.54 $792 - $916
-30 Reduced 7.83%
353 $10,000
Q1 2022

May 13, 2022

BUY
$23.07 - $27.99 $8,835 - $10,720
383 New
383 $10,000
Q3 2021

Nov 12, 2021

SELL
$23.37 - $32.13 $8,202 - $11,277
-351 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$18.78 - $25.15 $4,864 - $6,513
259 Added 281.52%
351 $8,000
Q1 2021

May 11, 2021

BUY
$18.21 - $23.2 $1,675 - $2,134
92 New
92 $1,000
Q1 2019

May 10, 2019

SELL
$28.4 - $36.49 $52,540 - $67,506
-1,850 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$53.61 - $67.26 $99,178 - $124,431
1,850 New
1,850 $107,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.55B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.